Loading...

Carol M Richman, MD

Title(s)Professor Emeritus, Hematology and Oncology
SchoolUniversity of California, Davis
AddressCancer Center
CA 95817
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis. Br J Haematol. 2018 09; 182(6):916-920. Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, Linhares Y, Mori S, Nash R, Pawarode A, Perales MA, Phipps CD, Richman C, Savani BN, Shapira MY, Stiff P, Strair R, Fenske TS, Smith SM, Sureda A, Olteanu H, Hamadani M. PMID: 28771676.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    2. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant. 2013 Aug; 19(8):1238-43. Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, Socié G, Tolar J, Williams KM, Eapen M, Savage SA. PMID: 23751955.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    3. Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1192-8. Lehmann J, DeNardo GL, Yuan A, Shen S, O'Donnell RT, Richman CM, DeNardo SJ. PMID: 16965873.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7187s-7194s. DeNardo SJ, Richman CM, Albrecht H, Burke PA, Natarajan A, Yuan A, Gregg JP, O'Donnell RT, DeNardo GL. PMID: 16203820.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    5. Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers? Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7158s-7163s. Miers L, Lamborn K, Yuan A, Richman C, Natarajan A, DeNardo S, DeNardo G. PMID: 16203816.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    6. High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody. Clin Cancer Res. 2005 Aug 15; 11(16):5920-7. Richman CM, Denardo SJ, O'Donnell RT, Yuan A, Shen S, Goldstein DS, Tuscano JM, Wun T, Chew HK, Lara PN, Kukis DL, Natarajan A, Meares CF, Lamborn KR, DeNardo GL. PMID: 16115934.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCTClinical Trials
    7. Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry. J Nucl Med. 2005 Jun; 46(6):1034-41. Shen S, DeNardo SJ, Richman CM, Yuan A, Siantar CH, O'Donnell RT, Kroger LA, DeNardo GL. PMID: 15937317.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    8. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004 Sep-Oct; 10(5):294-300. Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN. PMID: 15530258.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    9. Acute myocardial infarction in hemoglobin SC disease. Ann Hematol. 2004 Oct; 83(10):622-4. Wang H, Laslett LJ, Richman CM, Wun T. PMID: 15300406.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature. Am J Hematol. 2004 Apr; 75(4):231-8. Rodler E, Welborn J, Hatcher S, Unger K, Larkin E, Gumerlock PH, Wun T, Richman C. PMID: 15054816.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    11. Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3938S-44S. DeNardo SJ, DeNardo GL, Yuan A, Richman CM, O'Donnell RT, Lara PN, Kukis DL, Natarajan A, Lamborn KR, Jacobs F, Siantar CL. PMID: 14506192.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs. Cancer Biother Radiopharm. 2003 Apr; 18(2):231-7. DeNardo G, Yuan A, Goldstein D, Richman C, O'Donnell R, Shen S, Hartmann Siantar C, DeNardo S. PMID: 12804049.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. Transfusion. 2002 Dec; 42(12):1567-72. Hutchinson K, Kopko PM, Muto KN, Tuscano J, O'Donnell RT, Holland PV, Richman C, Paglieroni TG, Wun T. PMID: 12473136.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Filgrastim treatment of acute myelogenous leukemia (M7) relapse after allogeneic peripheral stem cell transplantation resulting in both graft-versus-leukemia effect with cytogenetic remission and chronic graft-versus-host disease manifesting as polyserositis and subsequent bronchiolitis obliterans with organizing pneumonia. Int J Hematol. 2002 Nov; 76(4):360-4. Law L, Tuscano J, Wun T, Ahlberg K, Richman C. PMID: 12463601.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial. Am J Hematol. 2002 Jul; 70(3):191-4. Wang SE, Lara PN, Lee-Ow A, Reed J, Wang LR, Palmer P, Tuscano JM, Richman CM, Beckett L, Wun T. PMID: 12111764.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    16. Isolated cavernous sinus extramedullary relapse of chronic myelogenous leukemia following allogeneic stem cell transplant. Ann Hematol. 2002 Feb; 81(2):108-10. Martel L, Reddy K, Greco M, Tuscano M, Richman M, Wun T. PMID: 11907793.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer. Clin Cancer Res. 2001 Jun; 7(6):1561-8. O'Donnell RT, DeNardo SJ, Yuan A, Shen S, Richman CM, Lara PN, Griffith IJ, Goldstein DS, Kukis DL, Martinez GS, Mirick GR, DeNardo GL, Meyers FJ. PMID: 11410491.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCTClinical Trials
    18. Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies. Crit Rev Oncol Hematol. 2001 Apr; 38(1):25-35. Richman CM, DeNardo SJ. PMID: 11255079.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    19. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001 Mar 15; 19(6):1728-33. Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. PMID: 11251003.
      View in: PubMed   Mentions: 160     Fields:    Translation:Humans
    20. Strategies for developing effective radioimmunotherapy for solid tumors. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3219s-3223s. DeNardo GL, O'Donnell RT, Kroger LA, Richman CM, Goldstein DS, Shen S, DeNardo SJ. PMID: 10541367.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    21. Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3243s-3248s. Richman CM, DeNardo SJ, O'Donnell RT, Goldstein DS, Shen S, Kukis DL, Kroger LA, Yuan A, Boniface GR, Griffith IJ, DeNardo GL. PMID: 10541370.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    22. Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol. Anticancer Res. 1998 Nov-Dec; 18(6A):4011-8. Denardo SJ, Richman CM, Kukis DL, Shen S, Lamborn KR, Miers LA, Kroger LA, Perez EA, Denardo GL. PMID: 9891439.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    23. Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts. Clin Cancer Res. 1998 Oct; 4(10):2483-90. DeNardo GL, Kroger LA, Meares CF, Richman CM, Salako Q, Shen S, Lamborn KR, Peterson JJ, Miers LA, Zhong GR, DeNardo SJ. PMID: 9796981.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    24. Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma. Cancer. 1997 Dec 15; 80(12 Suppl):2583-90. DeNardo SJ, Kroger LA, Lamborn KR, Miers LA, O'Donnell RT, Kukis DL, Richman CM, DeNardo GL. PMID: 9406713.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    25. Peripheral blood stem cell mobilization for hematopoietic support of radioimmunotherapy in patients with breast carcinoma. Cancer. 1997 Dec 15; 80(12 Suppl):2728-32. Richman CM, Schuermann TC, Wun T, Malik R, O'Donnell RT, DeNardo GL, DeNardo SJ. PMID: 9406731.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial. J Nucl Med. 1997 Aug; 38(8):1180-5. DeNardo SJ, Kramer EL, O'Donnell RT, Richman CM, Salako QA, Shen S, Noz M, Glenn SD, Ceriani RL, DeNardo GL. PMID: 9255145.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    27. Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer. Anticancer Res. 1997 May-Jun; 17(3B):1735-44. Denardo SJ, Richman CM, Goldstein DS, Shen S, Salako Q, Kukis DL, Meares CF, Yuan A, Welborn JL, Denardo GL. PMID: 9179227.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    28. Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody. Anticancer Res. 1997 May-Jun; 17(3B):1745-51. Denardo SJ, O'Grady LF, Richman CM, Goldstein DS, O'Donnell RT, Denardo DA, Kroger LA, Lamborn KR, Hellström KE, Hellström I, Denardo GL. PMID: 9179228.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCTClinical Trials
    29. Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions. Cancer Res. 1995 Dec 01; 55(23 Suppl):5916s-5920s. Richman CM, DeNardo SJ, O'Grady LF, DeNardo GL. PMID: 7493370.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    30. Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation. J Clin Oncol. 1994 Feb; 12(2):342-6. Ghalie R, Richman CM, Adler SS, Cobleigh MA, Korenblit AD, Manson SD, McLeod BC, Taylor SG, Valentino LA, Wolter J. PMID: 8113841.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. Sequential transplants using mobilized peripheral blood progenitor cells. J Clin Apher. 1994; 9(3):176-82. Ghalie R, Richman CM, Bender JG, McLeod BC, Lee W, Czyzewski A, Manson S, Cobleigh MA, Reed S, Pierre R. PMID: 7535760.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Overview of radioimmunotherapy in advanced breast cancer using I-131 chimeric L6. Adv Exp Med Biol. 1994; 353:203-11. DeNardo SJ, O'Grady LF, Richman CM, DeNardo GL. PMID: 7527179.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCTClinical Trials
    33. Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation. Am J Hematol. 1993 Apr; 42(4):350-3. Ghalie R, Porter C, Radwanska E, Fitzsimmons W, Richman C, Kaizer H. PMID: 8493984.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    34. Enhancement of clinical radioimmunotherapy for cancer and the role of cytokines. J Natl Cancer Inst. 1992 Mar 18; 84(6):374-5. DeNardo SJ, DeNardo GL, Richman CM. PMID: 1538409.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    35. Peripheral blood stem cell transplantation: impact on procedure load and workload in an apheresis unit. J Clin Apher. 1992; 7(4):201-7. Ghalie R, McLeod B, Richman C, Valentino L, Manson S, Netols C, Kaizer H. PMID: 1363730.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Involved field radiation, fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas. Bone Marrow Transplant. 1991 Jul; 8(1):41-5. Ghalie R, Richman CM, Adler SS, Korenblit AD, Kramer TS, Manson S, Dolce A, Kaizer H. PMID: 1912954.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity. J Biol Response Mod. 1990 Dec; 9(6):570-5. Richman CM, Slapak CA, Toh B. PMID: 1705960.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    38. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia. Exp Hematol. 1989 Dec; 17(11):1105-9. Murphy PB, Richman CM. PMID: 2583254.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    39. Granulocyte/macrophage progenitor cells from peripheral blood and bone marrow differ in their response to prostaglandin E1. Blood. 1987 Dec; 70(6):1792-6. Richman CM, Johnson GD. PMID: 3499944.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    40. Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma. Oncology. 1986; 43(1):12-7. Richman CM, Podczaski E, Weiser PA, Herbst AL. PMID: 3079898.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Differential protection of normal and malignant human myeloid progenitors (CFU-GM) from Ara-C toxicity using cycloheximide. Blood. 1985 Oct; 66(4):830-4. Slapak CA, Fine RL, Richman CM. PMID: 3862435.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    42. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy. Obstet Gynecol. 1985 Feb; 65(2):257-63. Richman CM, Holt JA, Lorincz MA, Herbst AL. PMID: 3969239.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Treatment of myeloid blastic crisis of chronic myelogenous leukemia. Cancer Treat Rep. 1984 Nov; 68(11):1351-5. Preisler HD, Raza A, Higby D, Kirshner J, Woll J, Bennett J, Winton L, Weiner R, Richman C, Golomb H. PMID: 6388833.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. The effect of lithium carbonate on chemotherapy-induced neutropenia and thrombocytopenia. Am J Hematol. 1984 May; 16(4):313-23. Richman CM, Makii MM, Weiser PA, Herbst AL. PMID: 6426295.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    45. Prolonged cryopreservation of human granulocytes. Transfusion. 1983 Nov-Dec; 23(6):508-11. Richman CM. PMID: 6649027.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    46. Cholesterol and mevalonic acid are independent requirements for the in vitro proliferation of human bone marrow granulocyte progenitor cells: studies using ML-236B. Blood. 1983 Apr; 61(4):667-71. Hoffman PC, Richman CM, Larson RA, Yachnin S. PMID: 6831033.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    47. Correlation of in vitro culture pattern and Q-banded karyotype in acute nonlymphocytic leukemia. Am J Hematol. 1983 Feb; 14(1):37-47. Richman CM, Rowley JD. PMID: 6837567.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    48. Prolonged cryopreservation of human bone marrow. Transplantation. 1981 Jun; 31(6):454-7. Parker LM, Binder N, Gelman R, Richman CM, Weiner RS, Yankee RA. PMID: 7256827.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    49. Granulopoietic effects of lithium on human bone marrow in vitro. Exp Hematol. 1981 Apr; 9(4):449-55. Richman CM, Kinnealey A, Hoffman PC. PMID: 6972319.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    50. Effect of oxygenated sterol compounds on human bone marrow granulocytic progenitor cells. Blood. 1981 Jan; 57(1):164-9. Hoffman PC, Richman CM, Hsu RC, Chung J, Scanu AM, Yachnin S. PMID: 7448408.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    51. Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer. 1980 Aug 15; 46(4):669-74. Parker LM, Griffiths CT, Yankee RA, Canellos GP, Gelman R, Knapp RC, Richman CM, Tobias JS, Weiner RS, Frei E. PMID: 7397632.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    52. Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiency. J Clin Invest. 1980 Aug; 66(2):389-95. Rich KC, Richman CM, Mejias E, Daddona P. PMID: 7400322.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosome. Blood. 1980 Aug; 56(2):262-4. Roth DG, Richman CM, Rowley JD. PMID: 6930980.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    54. Hairy cell leukemia: effect of 'hairy' cells on normal granulopoiesis in vitro. Exp Hematol. 1979 Sep; 7(8):411-5. Richman CM, Golomb HM. PMID: 315881.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    55. Dilution techniques for optimum recovery of cryopreserved bone marrow cells. Exp Hematol. 1979; 7 Suppl 5:1-6. Weiner RS, Richman CM, Yankee RA. PMID: 263236.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    56. Clinical results of autotransplantation after nitrosourea therapy. Exp Hematol. 1979; 7 Suppl 5:384-8. Weiner RS, Richman CM, Yankee RA, Parker L. PMID: 400701.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Purification and characterization of granulocytic progenitor cells (CFU-C) from human peripheral blood using immunologic surface markers. Blood. 1978 Jan; 51(1):1-8. Richman CM, Chess L, Yankee RA. PMID: 338057.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    58. Cryopreserved autologous marrow infusion following high dose cancer chemotherapy. Eur J Cancer. 1977 Mar 29; 13(3):269-77. Tobias JS, Weiner RS, Giffiths CT, Richman CM, Parker LM, Yankee RA. PMID: 324770.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    59. Semicontinuous flow centrifugation for the pheresis of immunocompetent cells and stem cells. Blood. 1977 Mar; 49(3):391-7. Weiner RS, Richman CM, Yankee RA. PMID: 138455.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    60. Increase in circulating stem cells following chemotherapy in man. Blood. 1976 Jun; 47(6):1031-9. Richman CM, Weiner RS, Yankee RA. PMID: 1276467.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells